Reduced upper airway nitric oxide in cystic fibrosis

Archives of Disease in Childhood

Volumn 75, Issue 4, 1996, Pages 319-322

  Balfour Lynn, Ian M ^a   Laverty, Aidan ^a   Dinwiddie, Robert ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Inhaled glucocorticoids; Lung inflammation,; Nitric oxide

Indexed keywords

GLUCOCORTICOID; NITRIC OXIDE;

ADOLESCENT; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029954579     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.4.319     Document Type: Article

References (30)

1. Konstan MW, Berger M. Infection and inflammation of the lung in cystic fibrosis. In: Davis PB, ed. Cystic fibrosis. New York: Marcel Dekker, 1993.
2. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV, Cystic Fibrosis Foundation Prednisone Trial Group. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr 1995;126:515-23.
3. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332:848-54.
4. Balfour-Lynn IM, Dinwiddie R. Role of corticosteroids in cystic fibrosis lung disease. J R Soc Med 1996;89(suppl 27):8-13.
5. Ramsay BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation Consensus Conference. J Pediatr 1994;124:177-92.
6. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair RB, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
7. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993;48:1034-43.
8. Jain B, Rubinstein I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Comm 1993;191:83-8.
9. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharm Rev 1991;43:109-42:
10. Liew FY, Cox FEG, Nonspecific defence mechanism: the role of nitric oxide, Immunol Today 1991;12:A17-21.
11. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Env Micro 1983;46: 198-202.
12. Croen KD. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type I replication. J Clin Invest 1993;91:2446-52.
13. Karupiah G, Xie Q-W, Buller RML, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 1993; 261:1445-48.
14. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Resp Crit Care Med 1994;149:538-51.
15. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea-pigs and humans. Biochem Biophys Res Commun 1991;181:852-7.
16. Alving K, Weitzberg E, Lundberg JM. Increased amounts of nitric oxide in exhaled air of asthmatics. Eur Resp J 1993;6: 1368-70.
17. Kharitonov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Resp Crit Care Med 1995;151:1889-93.
18. Kharitonov SA, Rajakulasingamm KR, O'Connor BJ, Durham SR, Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticosteroids [abstr]. Thorax 1995;50(suppl 2):A32.
19. Kharitinov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Resp Crit Care Med 1996;153:454-7.
20. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
21. Belvisi M, Barnes PJ, Larkin S, et al. Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 1995;283:255-8.
22. Greally P, Hussein MJ, Cook AJ, Sampson AP, Piper PJ, Price JF. Sputum tumour necrosis factor-α and leukotriene concentrations in cystic fibrosis. Arch Dis Child 1993;68: 389-92.
23. Balough K, McCubbins M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995;20:63-70.
24. Rosenthal M, Bain SH, Cramer D, et al. Lung function in white children aged 4 to 19 years. I. Spirometry. Thorax 1993;48:794-802.
25. Leone AM, Gustafsson LE, Francis PL, Persson MG, Wiklund NP, Moncada S. Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun 1994;201:883-7.
26. Grasemann H, Ioannidis I, Wallot M, de Groot H, Ratjen F. Airway nitric oxide (NO) in cystic fibrosis [abstr]. Am J Respir Crit Care Med 1996;153:A70.
27. Warren JB, Loi R, Rendell NB, Taylor GW. Nitric oxide is inactivated by the bacterial pigment pyocyanin. Biochem J 1990;266:921-3.
28. Lundberg JON, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nature Med 1995;1:370-3.
29. Ramsey B, Richardson MA. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol 1992;90:547-52.
30. Lundberg JON, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Resp J 1994;7:1501-4.